Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathwayZhangxiao Peng, Changqing Su|Scientific Reports|2017Cited by 96